Pacific Biosciences Of California PACB
NASDAQ PACB
$1.22 -0.05 (-3.94%)
As of: Aug 20, 2026 · 3:59 PM EDT

Pacific Biosciences Of California (PACB) Non-Current Deferred Tax Liability (2020 - 2022)

Pacific Biosciences Of California (PACB) posted quarterly Non-Current Deferred Tax Liability of $835000.0 for Q4 2022, little changed year-over-year from $838000.0 in Q4 2021, and little changed quarter-over-quarter from $838000.0 in Q4 2021.

Pacific Biosciences Of California (PACB) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends

Pacific Biosciences Of California's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $835000.0 for Q4 2022.

  • In Q4 2022, Non-Current Deferred Tax Liability changed 0.36% year-over-year to $835000.0; the TTM figure through Dec 2022 stood at $835000.0 (changed 0.36% YoY), while the FY2022 annual figure was $835000.0, changed 0.36% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2022 stood at $835000.0, roughly flat from $838000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $838000.0 in Q4 2021, with the low at $786000.0 in Q4 2020.
  • The 3-year median for Non-Current Deferred Tax Liability is $835000.0 (2022), against an average of $819666.7.
  • The sharpest annual moves came in 2021 and 2022: Non-Current Deferred Tax Liability climbed 6.62% in 2021, then fell 0.36% in 2022.
  • Pacific Biosciences Of California's Non-Current Deferred Tax Liability stood at $786000.0 in 2020, then rose by 6.62% to $838000.0 in 2021, then declined by 0.36% to $835000.0 in 2022.
  • Business Quant data shows PACB's Non-Current Deferred Tax Liability at $835000.0 in Q4 2022, $838000.0 in Q4 2021, and $786000.0 in Q4 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Pacific Biosciences Of California 381.79 Mn 144.92 Mn 12.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 835,000.00
Dec 31, 2022 835,000.00
Dec 31, 2021 838,000.00
Dec 31, 2021 838,000.00
Dec 31, 2020 786,000.00
Dec 31, 2020 786,000.00